Question 1

What is the catalog number for rAAV-GFAP-jGCaMP7c variant 1513-WPREs?

Accepted Answer

The catalog number for rAAV-GFAP-jGCaMP7c variant 1513-WPREs is PT-4304.

Question 2

What sizes are available for rAAV-GFAP-jGCaMP7c variant 1513-WPREs?

Accepted Answer

rAAV-GFAP-jGCaMP7c variant 1513-WPREs is available in the following size(s): 1 vial.

Question 3

Is rAAV-GFAP-jGCaMP7c variant 1513-WPREs in stock?

Accepted Answer

rAAV-GFAP-jGCaMP7c variant 1513-WPREs is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Are there any special shipping requirements for rAAV-GFAP-jGCaMP7c variant 1513-WPREs?

Accepted Answer

rAAV-GFAP-jGCaMP7c variant 1513-WPREs is requires dry ice shipping.

Question 5

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 6

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Question 7

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

rAAV-GFAP-jGCaMP7c variant 1513-WPREs

Product Specifications

Frequently Asked Questions

Explore Other Products

Anti-Matrix metalloproteinase-14 MMP14 Antibody Picoband®, Carrier-free

Anti-FGF2 Antibody Picoband®

Anti-Cyclophilin A/PPIA Antibody Picoband®

STAT5B (STAT5B/2611), CF488A conjugate, 0.1mg/mL

HLA-DRB (LN-3), CF405S conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF740 conjugate, 0.1mg/mL